Skip to main content
logo
Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.230
+0.150 (7.21%)
At close: Sep 17, 2026, 4:00 PM EDT
2.240
+0.010 (0.45%)
Pre-market: Sep 18, 2026, 5:18 AM EDT

Valion Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1.181.841.26
Revenue Growth
----36.09%46.38%46.16%
Cost of Revenue
---0.891.541.3
Gross Profit
---0.290.3-0.04
Selling, General & Admin
10.24.773.166.888.674.72
Research & Development
6.73.131.311.661.730.88
Operating Expenses
16.97.94.488.5310.45.6
Operating Income
-16.9-7.9-4.48-8.25-10.1-5.63
Interest Expense
-1.49-0.15----1.82
Interest & Investment Income
0.050.020.0100-
Other Non Operating Income (Expenses)
0.110.03---0.6
EBT Excluding Unusual Items
-18.23-7.99-4.47-8.24-10.1-6.86
Other Unusual Items
------1.64
Pretax Income
-18.23-7.99-4.47-8.24-10.1-8.49
Earnings From Continuing Operations
-18.23-7.99-4.47-8.24-10.1-8.49
Earnings From Discontinued Operations
-0.52-0.89-1.19---
Net Income
-18.75-8.88-5.66-8.24-10.1-8.49
Net Income to Common
-19.23-8.88-5.66-8.24-10.1-8.49
Net Income Growth
------
Shares Outstanding (Basic)
000---
Shares Outstanding (Diluted)
000---
Shares Change
296.62%302.10%----
EPS (Basic)
-210.20-192.08-491.95---
EPS (Diluted)
-210.20-192.08-491.95---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.67-7.04-5.73-8.63-8.93-5.61
Free Cash Flow Per Share
-160.40-152.25-498.04---
Gross Margin
---24.40%16.25%-3.02%
Operating Margin
----701.11%-548.80%-448.13%
Profit Margin
----701.02%-548.70%-675.74%
Free Cash Flow Margin
----733.76%-485.33%-446.46%
EBITDA
-16.54-7.89-4.47-8.24-10.09-5.63
D&A For EBITDA
0.370.0100.010.010.01
EBIT
-16.9-7.9-4.48-8.25-10.1-5.63
SEC Filings: 10-K · 10-Q